These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 7275529

  • 21. Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village.
    West SK, Munoz B, Mkocha H, Gaydos C, Quinn T.
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1492-7. PubMed ID: 17389476
    [Abstract] [Full Text] [Related]

  • 22. Conjunctival Microbiome-Host Responses Are Associated With Impaired Epithelial Cell Health in Both Early and Late Stages of Trachoma.
    Pickering H, Palmer CD, Houghton J, Makalo P, Joof H, Derrick T, Goncalves A, Mabey DCW, Bailey RL, Burton MJ, Roberts CH, Burr SE, Holland MJ.
    Front Cell Infect Microbiol; 2019 Apr; 9():297. PubMed ID: 31552195
    [Abstract] [Full Text] [Related]

  • 23. The role of spermatozoa in the pathogenesis of Chlamydia trachomatis salpingitis in a primate model.
    Patton DL, Wolner-Hanssen P, Zeng W, Lampe M, Wong K, Stamm WE, Holmes KK.
    Sex Transm Dis; 1993 Apr; 20(4):214-9. PubMed ID: 8211539
    [Abstract] [Full Text] [Related]

  • 24. Inapparent ocular infection by Chlamydia trachomatis in experimental and human trachoma.
    Hudson AP, McEntee CM, Reacher M, Whittum-Hudson JA, Taylor HR.
    Curr Eye Res; 1992 Mar; 11(3):279-83. PubMed ID: 1375138
    [Abstract] [Full Text] [Related]

  • 25. [Identification of latent forms of Chlamydia trachomatis in the conjunctiva signifying "new interpretation of ocular chlamydia infections"].
    Verin P, Mortemousque B, Gendre P, Barac'H D, Dorot N, Chraibi-Hasseini K.
    Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique; 1997 Mar; 74():65-74. PubMed ID: 9889578
    [Abstract] [Full Text] [Related]

  • 26. Cicatrizing conjunctivitis.
    Wright P.
    Trans Ophthalmol Soc U K (1962); 1986 Mar; 105 ( Pt 1)():1-17. PubMed ID: 3520979
    [No Abstract] [Full Text] [Related]

  • 27. Experimental trachoma.
    Verin P.
    Rev Int Trach Pathol Ocul Trop Subtrop; 1979 Mar; 56(3-4):8-61. PubMed ID: 120577
    [No Abstract] [Full Text] [Related]

  • 28. Trachoma: an overview.
    Burton MJ.
    Br Med Bull; 2007 Mar; 84():99-116. PubMed ID: 18175788
    [Abstract] [Full Text] [Related]

  • 29. Laboratory investigations on viral and Chlamydia trachomatis infections of the eye: Sankara Nethralaya experiences.
    Madhavan HN.
    Indian J Ophthalmol; 1999 Dec; 47(4):241-6. PubMed ID: 10892481
    [Abstract] [Full Text] [Related]

  • 30. Chlamydia conjunctivitis.
    Delgadillo RA, Muylaert LD, Vanden Berghe DA, Neetens A.
    Bull Soc Belge Ophtalmol; 1983 Dec; 207():97-107. PubMed ID: 6680048
    [No Abstract] [Full Text] [Related]

  • 31. The effect of cyclosporine in chlamydial eye infection.
    Young E, Schachter J, Prendergast RA, Taylor HR.
    Curr Eye Res; 1987 May; 6(5):683-9. PubMed ID: 3595180
    [Abstract] [Full Text] [Related]

  • 32. Method for detection of conjunctival chlamydial infection and allergic conjunctivitis.
    Van Ginderdeuren R, Missotten L.
    Bull Soc Belge Ophtalmol; 1994 May; 254():55-7. PubMed ID: 7493124
    [Abstract] [Full Text] [Related]

  • 33. [Recurrent canaliculitis and dacryocystitis as a sequela of persistent infection with Chlamydia trachomatis].
    Janssen K, Gerding H, Busse H.
    Ophthalmologe; 1993 Feb; 90(1):17-20. PubMed ID: 8443442
    [Abstract] [Full Text] [Related]

  • 34. The ophthalmologist's role in Chlamydia trachomatis infection.
    Mancino R, Valli E, Cedrone C, Nucci C, D'Ambrosi E, Cerulli L.
    Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique; 1994 Feb; 71():79-83. PubMed ID: 8724804
    [Abstract] [Full Text] [Related]

  • 35. Risk factors for postsurgical trichiasis recurrence in a trachoma-endemic area.
    West ES, Mkocha H, Munoz B, Mabey D, Foster A, Bailey R, West SK.
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):447-53. PubMed ID: 15671268
    [Abstract] [Full Text] [Related]

  • 36. Evaluation of serological tests for screening of chlamydial eye diseases.
    Numazaki K, Chiba S, Aoki K.
    In Vivo; 1999 Feb; 13(3):235-7. PubMed ID: 10459498
    [Abstract] [Full Text] [Related]

  • 37. Expression of MHC class II antigens by conjunctival epithelial cells in trachoma: implications concerning the pathogenesis of blinding disease.
    Mabey DC, Bailey RL, Dunn D, Jones D, Williams JH, Whittle HC, Ward ME.
    J Clin Pathol; 1991 Apr; 44(4):285-9. PubMed ID: 2030145
    [Abstract] [Full Text] [Related]

  • 38. Frequency of antigen-specific B cells during experimental ocular Chlamydia trachomatis infection.
    Pal S, Taylor HR, Huneke RB, Prendergast RA, Whittum-Hudson JA.
    Infect Immun; 1992 Dec; 60(12):5294-7. PubMed ID: 1452363
    [Abstract] [Full Text] [Related]

  • 39. Infection of rhesus and cynomolgus monkeys with egg-grown viruses of trachoma and inclusion conjunctivitis.
    DAWSON CR, MORDHORST CH, THYGESON P.
    Ann N Y Acad Sci; 1962 Mar 05; 98():167-76. PubMed ID: 13884031
    [No Abstract] [Full Text] [Related]

  • 40. Immunohistochemical study of the local inflammatory response to chlamydial ocular infection.
    Whittum-Hudson JA, Taylor HR, Farazdaghi M, Prendergast RA.
    Invest Ophthalmol Vis Sci; 1986 Jan 05; 27(1):64-9. PubMed ID: 3484473
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.